A2M 17th $2 +, page-285

There are various reasons to be negative/cautious about A2. These include:
1) US expansion failure
2) US expansion costs (7m a year for 3 years)
3) UK expansion failure
4) Regulatory changes regarding the export of IF to china
5) Slowing growth in IF and competitive offerings from rivals which steal market share.
6) Negative findings regarding A2 protein.
7) Production constraints.

Now, I believe I have covered the risks and downsides of an investment into A2m more then hotkey has in 200 posts. I have no issue with people sharing these concerns (as these points concern me) although most people here disliked hotkey for his uninformative posts and deflamatory arguments with other HC member.

I agree with your point on banking profit although this may be a better idea after a CGT discount is available (12 months of holding).